Nini Wu

1 week ago | ajmc.com | Giuliana Grossi |Nini Wu

Among the most promising trends in oncology over the past year is the growing ability to deliver advanced therapies, such as chimeric antigen receptor (CAR) T and bispecific treatments, closer to patients’ homes, according to Nini Wu, MD, MBA, chief medical and development officer at Navista, Cardinal Health.